McDonald's posts rare profit miss, shares down 4%
(Reuters) - McDonald's Corp
The company has been battling competition in the United States, especially in the past few quarters, from rival fast-food chains that are challenging McDonald's dominance with value meals and plant-based food options.
McDonald's was late to the game in offering plant-based burgers, behind rivals Restaurant Brands'
In a bid to reverse declining customer traffic and tackle competition, McDonald's has been remodeling its 14,000 U.S. restaurants to include digital ordering kiosks, mobile ordering as well as pay and pickup services.
It has also been spending heavily on delivery by partnering with app-based delivery services GrubHub
Sales at U.S. restaurants open for at least 13 months rose 4.8% in the third quarter ended Sept. 30, below the 5.17% growth expected by analysts, according to IBES data from Refinitiv.
Globally, McDonald's reported better-than-expected comparable sales growth of 5.9%, driven by strong growth in markets such as the UK and France.
Net income fell 2% to $1.61 billion, in the quarter from $1.64 billion, a year earlier.
On a per share basis, the company earned $2.11 per share missing expectations of $2.21.
Total revenue, including both U.S. and overseas operations, rose to $5.43 billion, slightly below analysts' expectations of $5.49 billion.
(Reporting by Aishwarya Venugopal in Bengaluru and Hilary Russ in New York; Editing by Anil D'Silva)
More News in Business
Investors sentiment decreased to 0.7 in Q2 2019. Its down 0.18, from 0.88 in 2019Q1. It turned negative, as 82 investors sold Biogen Inc. shares while 316 reduced holdings. 78 funds
By Ryan Adsit In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Biogen Inc ( BIIB - Research Report), with a price target of $275.00. The
In the United States, approximately 3.3 million dogs enter shelters every year, out of which approximately 35 percent are eventually put down. Against this backdrop of local shelters getting overcrowded, National Make a Dog's Day,
Biogen (NASDAQ:BIIB)'s stock had its "hold" rating reissued by equities research analysts at Mizuho in a research report issued on Tuesday, AnalystRatings.com reports. They currently have a $235.00 target price on the biotechnology company's stock.
Brinker Capital Inc. decreased its holdings in shares of United Technologies Co. (NYSE:UTX) by 22.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 41,958 shares of
UPS announced its chief operating officer Jim Barber will retire at the end of the year. Barber, 59, was named COO last year. He had previously been president of international for UPS since 2013. Barber started